Prognostic value of KIT mutation in gastrointestinal stromal tumors

World Journal of Gastroenterology

Volumn 11, Issue 25, 2005, Pages 3948-3952

  Liu, Xiao Hong ^a   Bai, Chen Guang ^a   Xie, Qiang ^a   Feng, Fei ^a   Xu, Zhi Yun ^a   Ma, Da Lie ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

C kit oncogene; Gastrointestinal stromal tumor; Genet mutation; Prognostic factor

Indexed keywords

CYCLINE; DNA; STEM CELL FACTOR;

ADULT; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CELL COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DNA SEQUENCE; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MITOSIS; ONCOLOGICAL PARAMETERS; PATHOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; PROGNOSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TUMOR NECROSIS; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 22644431820     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i25.3948     Document Type: Article

References (19)

1. Wong NA, Young R, Malcomson RD, Nayar AG, Jamieson LA, Save VE, Carey FA, Brewster DH, Han C, Al-Nafussi A. Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology 2003; 43: 118-126
2. Nagasaco Y, Misawa K, Kohashi S, Hasegawa K, Okawa Y, Sano H, Takada A, Sato H. Evaluation of malignancy using Ki-67 labeling index for gastric stromal tumor. Gastric Cancer 2003; 6: 168-172
3. Kim MK, Lee JK, Park ET, Lee SH, Seol SY, Chung JM, Kang MS, Yoon HK. Gastrointestinal stromal tumors: clinical, pathologic features and effectiveness of new diagnostic criteria. Korean J Gastroenterol 2004; 43: 341-348
4. Lewin KJ, Riddle R, Weinstein W. Gastrointestinal Pathology and Its Clinical Implications. 2thnd. New York: Igaku-Shoin Medical Pub 1992: 284-341
5. Ballarini C, Intra M, Ceretti AP, Prestipino F, Bianchi FM, Sparacio F, Berti E, Perrone S, Silva F. Gastrointestinal stromal tumors: a "benign" tumor with hepatic metastasis after 11 years. Tumori 1998; 84: 78-81
6. Goldblum JR. Gastrointestinal stromal tumors. A review of characteristics morphologic, immunohistochemical, and molecular genetic features. Am J Clin Pathol 2002; 117(Suppl): S49-61
7. Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol 2004; 22: 3813-3825
8. Ma DL, Liu XH, Bai CG, Xie Q, Feng F. Effect of C-kit gene mutation on prognosis of gastrointestinal stromal tumor. Zhonghua Waike Zazhi 2004; 42: 140-144
9. Theou N, Tabone S, Saffroy R, Le Cesne A, Julie C, Cortez A, Lavergne-Slove A, Debuire B, Lemoine A, Emile JF. High expression of both mutant and wild-type alleles of C-kit in gastroir testinal stromal tumors. Biochim Biophys Acta 2004; 1688: 250-256
10. Pardanani A, Reeder TL, Kimlinger TK, Baek JY, Li CY, Butterfield JH, Tefferi A. Flt-3 and C-kit mutation studies in a spectrum of chronic myeloid disorders including systemic mast cell disease. Leuk Res 2003; 27: 739-742
11. Noack F, Escribano L, Sotlar K, Nunez R, Schuetze K, Valent P, Horny HP. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of C-kit mutation ASP-816-VAL. Leuk Lymphoma 2003; 44: 313-319
12. Sammarco I, Capurso G, Coppola L, Bonifazi AP, Cassetta S, Delle Fave G, Carrara A, Grassi GB, Rossi P, Sette C, Geremia R. Expression of the proto-oncogene C-kit in normal and tumor tissues from colorectal carcinoma patients. Int J Colorectal Dis 2004; 19: 545-553
13. Looijenga LH, de Leeuw H, van Oorschot M, van Gurp RJ, Stoop H, Gillis AJ, de Gouveia Brazao CA, Weber RF, Kirkels WJ, van Dijk T, von Lindern M, Valk P, Lajos G, Olah E, Nesland JM, Fossa SD, Oosterhuis JW. Stem cell factor receptor (C-kit) codon 816 mutations predict development of bilateral testicular germ-cell tumors. Cancer Res 2003; 63: 7674-7678
14. Beghini A, Tibiletti MG, Roversi G, Chiaravalli AM, Serio G, Capella C, Larizza L. Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa. Cancer 2001; 92: 657-662
15. Lee JR, Joshi V, Griffin JW Jr, Lasota J, Miettinen M. Gastrointestinal autonomic nerve tumor: immunohistochemical and molecular identity with gastrointestinal stromal tumor. Am J Surg Pathol 2001; 25: 979-987
16. Fukuda R, Hamamoto N, Uchida Y, Furuta K, Katsube T, Kazumori H, Ishihara S, Amano K, Adachi K, Watanabe M, Kinoshita Y. Gastrointestinal stromal tumor with a novel mutation of KIT proto-oncogene. Intern Med 2001; 40: 301-303
17. Hirota S, Nishida T, Isozaki K, Taniguchi M, Nakamura J, Okazaki T, Kitamura Y. Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours. J Pathol 2001; 193: 505-510
18. Taniguchi M, Nishida T, Hirota S, Isozaki K, Ito T, Nomura T, Matsuda H, Kitamura Y. Effect of C-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res 1999; 59: 4297-4300
19. Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D, Silberman SL, Capdeville R, Dimitrijevic S, Druker B, Demetri GD. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001; 344: 1052-1056